Using graph convolutional network to characterize individuals with major depressive disorder across multiple imaging

Kun Qin1, Du Lei2, Walter H L Pinaya3

  • 1Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, China; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA; Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital of Sichuan University, Chengdu, Sichuan, China; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Ebiomedicine
|April 3, 2022
PubMed
Summary

Graph convolutional networks (GCNs) show promise for diagnosing major depressive disorder (MDD) by analyzing brain connectivity. This advanced machine learning approach achieved high accuracy in a large, multi-site study, identifying key brain regions involved in MDD.